drugset / Trial / NCT01147497

Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women

NCT01147497

Completed 78 enrolled Emory University
RandomizedParallel-groupTriple-blindTreatment

Summary

Because of misoprostol's known ability to cause cervical dilation, some family planning providers give their patients a dose of this drug prior to insertion. The goal of this study is to evaluate whether misoprostol prior to IUD insertion in nulliparous women eases insertion and decreases pain.

Timeline

Start
2010-06
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Other

Indications

No indication recorded.